Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma. | Front Oncol | 2022 | 36338699 | PubTator, text mining | PubMed |
| Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review. | Clin Med Insights Oncol | 2022 | 36338263 | PubTator, text mining | PubMed |
| Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers. | Front Bioeng Biotechnol | 2022 | 36338118 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway. | J Clin Lab Anal | 2022 | 36336887 | PubTator, text mining | PubMed |
| lncRNA-AC130710/miR-129-5p/mGluR1 axis promote migration and invasion by activating PKCα-MAPK signal pathway in melanoma. | Open Med (Wars) | 2022 | 36329788 | PubTator, text mining | PubMed |
| LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway. | Cancer Biol Ther | 2022 | 36329030 | PubTator, text mining | PubMed |
| The LCNetWork: An electronic representation of the mRNA-lncRNA-miRNA regulatory network underlying mechanisms of non-small cell lung cancer in humans, and its explorative analysis. | Comput Biol Chem | 2022 | 36327779 | PubTator, text mining | PubMed |
| Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition. | Front Oncol | 2022 | 36313710 | PubTator, text mining | PubMed |
| The role of lncRNAs in regulation of DKD and diabetes-related cancer. | Front Oncol | 2022 | 36313695 | PubTator, text mining | PubMed |
| Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance. | Front Oncol | 2022 | 36313645 | PubTator, text mining | PubMed |
Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation. | Front Immunol | 2022 | 36311789 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma. | Front Mol Biosci | 2022 | 36310592 | PubTator, text mining | PubMed |
| GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a. | J Int Med Res | 2022 | 36310502 | PubTator, text mining | PubMed |
| LINC00589-dominated ceRNA networks regulate multiple chemoresistance and cancer stem cell-like properties in HER2+ breast cancer. | NPJ Breast Cancer | 2022 | 36309503 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in osteoarthritis: An updated review. | Front Immunol | 2022 | 36304464 | PubTator, text mining | PubMed |
| Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential. | Front Immunol | 2022 | 36300115 | PubTator, text mining | PubMed |
| Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network. | Contrast Media Mol Imaging | 2022 | 36299828 | PubTator, text mining | PubMed |
| Kidney diseases and long non-coding RNAs in the limelight. | Front Physiol | 2022 | 36299256 | PubTator, text mining | PubMed |
| Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology. | J Pers Med | 2022 | 36294743 | PubTator, text mining | PubMed |
| Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance. | Int J Mol Sci | 2022 | 36293127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=32